The Good and Bad of Those Ubiquitous Drug Ads October 28, 2015 News Release In his latest column for The Wall Street Journal’s Think Tank, Drew Altman examines the public’s mixed views about prescription drug ads and their impact on prescribing patterns, based on a new Kaiser Family Foundation survey. All previous columns by Drew Altman are available online.
How High Drug Prices Weigh on the Sickest Americans December 28, 2015 News Release In his latest column for The Wall Street Journal’s Think Tank, Drew Altman explores the data behind public concern about prescription drug costs and highlights that the people most in need are the most burdened by the problem. All previous columns by Drew Altman are online.
How Health-Care Bills Hinder Millions of Americans January 5, 2016 News Release In his latest column for The Wall Street Journal’s Think Tank, Drew Altman examines the problems many Americans with health insurance are having paying medical bills based on a new Kaiser-New York Times Survey, and discusses why the issue of the adequacy of insurance coverage is gaining traction. All previous columns…
In N.Y. Policy on Out-of-Network Medical Bills, a Model for Other States? January 11, 2016 News Release In his latest column for The Wall Street Journal’s Think Tank, Drew Altman discusses surprise bills for out-of-network care, and New York state’s solution to the problem. All previous columns by Drew Altman are online.
In N.Y. Policy on Out-of-Network Medical Bills, a Model for Other States? January 11, 2016 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman discusses surprise bills for out-of-network care, and New York state’s solution to the problem.
Visualizing Health Policy: A Snapshot of Cancer Spending and Outcomes June 21, 2016 News Release This Visualizing Health Policy infographic provides details on cancer spending and outcomes in the United States.
Visualizing Health Policy: A Snapshot of Cancer Spending and Outcomes June 21, 2016 Infographic This Visualizing Health Policy infographic provides details on cancer spending and outcomes in the United States. The U.S. cancer mortality rate, 203 deaths per 100,000 population, was slightly lower than in comparable countries in 2010. Among cancers, lung cancer is the largest contributor to disease burden for both men and…
What Are the Current Costs and Outcomes Related to Mental Health and Substance Abuse Disorders? May 6, 2016 Slideshow
Medicaid’s Most Costly Outpatient Drugs July 15, 2016 Issue Brief Using Medicaid State Drug Utilization Data, this brief presents the 50 most costly drugs before rebates used by the Medicaid program over the January 2014 through June 2015 period. It then examines reasons why these drugs are so costly; explores case studies on opioids, hepatitis C drugs, and the drug Abilify; and considers policy implications.
